Showing results (61-70 of 141) with videos related to
Sort By:
Pageof 15
Oncology Reports|January 19, 2008
Metastatic renal cancer and patient survival as a criterion of treatment responseGeorge P Stathopoulos, John Koutantos, Sotiris K Rigatos, et al.American Journal of Clinical Oncology|December 1, 2005
Efficacy and tolerability of oxaliplatin plus irinotecan 5-fluouracil and leucovorin regimen in advanced stage colorectal cancer patients pretreated with irinotecan 5-fluouracil and leucovorinGeorge P Stathopoulos, Sotiris K Rigatos, John G Stathopoulos, et al.Clinical Immunology (Orlando, Fla.)|July 9, 2026
Immunopathogenesis of NMDA receptor encephalitisΤ Dame, K Themas, E Repousi, et al.Journal of Cancer Research and Clinical Oncology|January 13, 2017
A retrospective open-label uncontrolled study of Epoetin zeta on the treatment of chemotherapy-induced anemia in solid tumorsConstantinos E Alifieris, Kyriakos Orfanakos, Aristina Papanota, et al.Anticancer Research|January 12, 2007
Angiosarcoma of the heart: case report and review of the literatureS Batzios, A Michalopoulos, L Kaklamanis, et al.Anticancer Research|January 12, 2000
Induction chemotherapy in non small cell lung cancer stage IIIa-b and IV and second-line treatmentG P Stathopoulos, U G Dafni, N A Malamos, et al.European Journal of Orthopaedic Surgery & Traumatology : Orthopedie Traumatologie|January 4, 2020
A new method for intraoperative assessment of leg length, sizing and placement of the components in total hip replacementIoannis P Stathopoulos, Nicolaos Andrianopoulos, Dimitrios Paschaloglou, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 21, 2002
A double-blind, randomised, parallel group, multinational, multicentre study comparing a single dose of ondansetron 24 mg p.o. with placebo and metoclopramide 10 mg t.d.s. p.o. in the treatment of opioid-induced nausea and emesis in cancer patientsJ Hardy, S Daly, B McQuade, et al.Cancer Chemotherapy and Pharmacology|March 8, 2006
Front-line paclitaxel and topotecan chemotherapy in advanced or metastatic non-small-cell lung cancer: a phase II trialG P Stathopoulos, C Katis, D Tsavdaridis, et al.Anticancer Research|August 6, 2005
Phase II study of cisplatin-combined schedules as second-line chemotherapy in patients with non-small cell lung cancerMarinos Veslemes, Dimosthenis Antoniou, Niki Georgatou, et al.Pageof 15